Cited by 335Receptor Mechanisms and SignalingNeuroscience and Neuropharmacology ResearchProtein Structure and Dynamics

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation

Open access

Staus, Dean P., Strachan, Ryan T., Manglik, Aashish, Pani, Biswaranjan, Kahsai, Alem W., Kim, Tae Hun, Wingler, Laura M., Ahn, Seungkirl, Chatterjee, Arnab, Masoudi, Ali, Kruse, Andrew C., Pardon, Els, Steyaert, Jan, Weis, William I., Prosser, R. Scott, Kobilka, Brian K., Costa, Tommaso, Lefkowitz, Robert J.·2016·Nature

DOI 10.1038/nature18636PMC PMC4961583

Open this paper in CoChat — free account

Abstract

G-protein-coupled receptors (GPCRs) modulate many physiological processes by transducing a variety of extracellular cues into intracellular responses. Ligand binding to an extracellular orthosteric pocket propagates conformational change to the receptor cytosolic region to promote binding and activation of downstream signalling effectors such as G proteins and β-arrestins. It is well known that different agonists can share the same binding pocket but evoke unique receptor conformations leading to a wide range of downstream responses (‘efficacy’). Furthermore, increasing biophysical evidence, primarily using the β2-adrenergic receptor (β2AR) as a model system, supports the existence of multiple active and inactive conformational states. However, how agonists with varying efficacy modulate these receptor states to initiate cellular responses is not well understood. Here we report stabilization of two distinct β2AR conformations using single domain camelid antibodies (nanobodies)—a previously described positive allosteric nanobody (Nb80) and a newly identified negative allosteric nanobody (Nb60). We show that Nb60 stabilizes a previously unappreciated low-affinity receptor state which corresponds to one of two inactive receptor conformations as delineated by X-ray crystallography and NMR spectroscopy. We find that the agonist isoprenaline has a 15,000-fold higher affinity for β2AR in the presence of Nb80 compared to the affinity of isoprenaline for β2AR in the presence of Nb60, highlighting the full allosteric range of a GPCR. Assessing the binding of 17 ligands of varying efficacy to the β2AR in the absence and presence of Nb60 or Nb80 reveals large ligand-specific effects that can only be explained using an allosteric model which assumes equilibrium amongst at least three receptor states. Agonists generally exert efficacy by stabilizing the active Nb80-stabilized receptor state (R80). In contrast, for a number of partial agonists, both stabilization of R80 and destabilization of the inactive, Nb60-bound state (R60) contribute to their ability to modulate receptor activation. These data demonstrate that ligands can initiate a wide range of cellular responses by differentially stabilizing multiple receptor states.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/nature18636

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Methods in Enzymology , Vol
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
MolProbity : all-atom structure validation for macromolecular crystallography
Chen, V. B., Arendall, W. B., Headd, J. J., Keedy, D. A., Immormino, R. M., Kapral, G. J., Murray, L. W., Richardson, J. S., & Richardson, D. C. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909042073 · Cited by 14,115
Modified Spin-Echo Method for Measuring Nuclear Relaxation Times
Meiboom, S., & Gill, D. (1958) · Review of Scientific Instruments · doi:10.1063/1.1716296 · Cited by 6,001
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citation
[19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors
Ballesteros, J. A., & Weinstein, H. (1995) · Methods in neurosciences · doi:10.1016/s1043-9471(05)80049-7 · Cited by 3,001
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,709
Self-citation

Flagged first, then by citations

Show all 38 references

Sorted by citations

Items 101–200 of 335

Decay of an active GPCR: Conformational dynamics govern agonist rebinding and persistence of an active, yet empty, receptor state
Schafer, C. T., Fay, J. F., Janz, J. M., & Farrens, D. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606347113 · Cited by 41
On the use of Pichia pastoris for isotopic labeling of human GPCRs for NMR studies
Clark, L. D., Dikiy, I., Rosenbaum, D. M., & Gardner, K. H. (2018) · Journal of Biomolecular NMR · doi:10.1007/s10858-018-0204-3 · Cited by 41
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
Laeremans, T., Sands, Z. A., Claes, P., Blieck, A. D., Cesco, S. D., Triest, S., Busch, A., Felix, D., Kumar, A., Jaakola, V., et al. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.863099 · Cited by 44
Bioactivity of the putative apelin proprotein expands the repertoire of apelin receptor ligands
Shin, K., Chapman, N. A., Sarker, M., Kenward, C., Huang, S. K., Weatherbee‐Martin, N., Pandey, A. N., Dupré, D. J., & Rainey, J. K. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.05.017 · Cited by 40
A Comprehensive Analysis of Anion–Quadrupole Interactions in Protein Structures
Chakravarty, S., Ung, A. R., Moore, B. G., Shore, J. S., & Alshamrani, M. S. (2018) · Biochemistry · doi:10.1021/acs.biochem.7b01006 · Cited by 40
Distinct Conformational Dynamics of Three G Protein-Coupled Receptors Measured Using FlAsH-BRET Biosensors
Bourque, K., Pétrin, D., Sleno, R., Devost, D., Zhang, A., & Hébert, T. E. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00061 · Cited by 38
A cDNA Immunization Strategy to Generate Nanobodies against Membrane Proteins in Native Conformation
Eden, T. W., Menzel, S., Wesolowski, J., Bergmann, P., Nissen, M., Dubberke, G., Seyfried, F., Albrecht, B., Haag, F., & Koch‐Nolte, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01989 · Cited by 38
Selective targeting of ligand-dependent and -independent signaling by GPCR conformation-specific anti-US28 intrabodies
Groof, T. W. M. D., Bergkamp, N. D., Heukers, R., Giap, T., Bebelman, M. P., Haas, R. R. D. G., Piersma, S. R., Jiménez, C. R., García, K. C., Ploegh, H. L., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24574-y · Cited by 38
Gonadotropin Hormones and Their Receptors
Narayan, P., Ulloa‐Aguirre, A., & Dias, J. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-47912-7.00002-0 · Cited by 38
High Pressure Shifts the β 1 -Adrenergic Receptor to the Active Conformation in the Absence of G Protein
Abiko, L. A., Grahl, A., & Grzesiek, S. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b06042 · Cited by 37
Capturing Peptide–GPCR Interactions and Their Dynamics
Kaiser, A., & Coin, I. (2020) · Molecules · doi:10.3390/molecules25204724 · Cited by 37
Learning About Allosteric Drugs and Ways to Design Them
Tan, Z. W., Tee, W.-V., & Berezovsky, I. N. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167692 · Cited by 37
IL-2 can signal via chemokine receptors to promote regulatory T cells’ suppressive function
Sun, H., Lee, H. S., Kim, S. H.-J., de Lima, M. F., Gingras, A. R., Du, Q., Puzon-McLaughlin, W., Ablack, J., Lopez‐Ramirez, M. A., Lagarrigue, F., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112996 · Cited by 36
Mutations in the NPxxY motif stabilize pharmacologically distinct conformational states of the α 1B - and β 2 -adrenoceptors
Ragnarsson, L. K. N., Andersson, Å., Thomas, W. G., & Lewis, R. J. (2019) · Science Signaling · doi:10.1126/scisignal.aas9485 · Cited by 37
Preassembled GPCR signaling complexes mediate distinct cellular responses to ultralow ligand concentrations
Civciristov, S., Ellisdon, A. M., Suderman, R., Pon, C. K., Evans, B. A., Kleifeld, O., Charlton, S. J., Hlavacek, W. S., Canals, M., & Halls, M. L. (2018) · Science Signaling · doi:10.1126/scisignal.aan1188 · Cited by 38
Structure-based identification of a G protein–biased allosteric modulator of cannabinoid receptor CB1
Shen, S., Wu, C., Lin, G., Yang, X., Zhou, Y., Zhao, C. S., Miao, Z., Tian, X., Wang, K., Yang, Z., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2321532121 · Cited by 34
Overview of follicle stimulating hormone and its receptors in reproduction and in stem cells and cancer stem cells
Haldar, S., Agrawal, H., Saha, S., Straughn, A. R., Roy, P., & Kakar, S. S. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.63721 · Cited by 35
HDX-MS-optimized approach to characterize nanobodies as tools for biochemical and structural studies of class IB phosphoinositide 3-kinases
Rathinaswamy, M. K., Fleming, K. D., Dalwadi, U., Pardon, E., Harris, N. J., Yip, C. K., Steyaert, J., & Burke, J. E. (2021) · Structure · doi:10.1016/j.str.2021.07.002 · Cited by 32
Self-citation
An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects
French, A. R., & van Rijn, R. M. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106091 · Cited by 32
Probing the correlation between ligand efficacy and conformational diversity at the α1A-adrenoreceptor reveals allosteric coupling of its microswitches
Wu, F., Williams, L. M., Abdul‐Ridha, A., Gunatilaka, A., Vaid, T. M., Kočan, M., Whitehead, A. R., Griffin, M. D. W., Bathgate, R. A. D., Scott, D. J., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012842 · Cited by 32
Function-related conformational dynamics of G protein–coupled receptors revealed by NMR
Ueda, T., Kofuku, Y., Okude, J., Imai, S., Shiraishi, Y., & Shimada, I. (2019) · Biophysical Reviews · doi:10.1007/s12551-019-00539-w · Cited by 31
30 years of nanobodies – an ongoing success story of small binders in biological research
Frecot, D. I., Fröhlich, T., & Rothbauer, U. (2023) · Journal of Cell Science · doi:10.1242/jcs.261395 · Cited by 31
Analysis of Biased Agonism
Ehlert, F. J. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2018.08.001 · Cited by 30
Agonist antibody discovery: Experimental, computational, and rational engineering approaches
Schardt, J. S., Jhajj, H. S., O’Meara, R. L., Lwo, T. S., Smith, M. D., & Tessier, P. M. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.008 · Cited by 32
Ligand-Specific Restriction of Extracellular Conformational Dynamics Constrains Signaling of the M2 Muscarinic Receptor
Bermúdez, M., Böck, A., Krebs, F., Holzgrabe, U., Mohr, K., Lohse, M. J., & Wolber, G. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00275 · Cited by 29
BRAIN Initiative: Cutting-Edge Tools and Resources for the Community
Litvina, E. Y., Adams, A. B., Barth, A. L., Bruchez, M. P., Carson, J. A., Chung, J. E., Dupre, K. B., Frank, L. M., Gates, K. M., Harris, K. M., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.1169-19.2019 · Cited by 28
An inactive receptor-G protein complex maintains the dynamic range of agonist-induced signaling
Jang, W., Adams, C., Liu, H., Zhang, C., Levy, F. O., Andressen, K. W., & Lambert, N. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2010801117 · Cited by 28
Biased signaling as allosteric probe dependence
Kenakin, T. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109844 · Cited by 28
The Potential of 19F NMR Application in GPCR Biased Drug Discovery
Wang, X., McFarland, A., Madsen, J. J., Aalo, E., & Ye, L. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.11.001 · Cited by 27
High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway
He, X., Zhang, Y., Yu, J., Gan, Y., Han, N., Zhang, M., Ge, W., Deng, J., Zheng, Y., & Xu, X. (2017) · Tumor Biology · doi:10.1177/1010428317695971 · Cited by 27
Transforming nanobodies into high-precision tools for protein function analysis
Gettemans, J., & Dobbelaer, B. D. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00435.2020 · Cited by 29
Unique Positive Cooperativity Between the β-Arrestin–Biased β-Blocker Carvedilol and a Small Molecule Positive Allosteric Modulator of the β2-Adrenergic Receptor
Pani, B., Ahn, S., Rambarat, P. K., Vege, S., Kahsai, A. W., Liu, A., Valan, B. N., Staus, D. P., Costa, T., & Lefkowitz, R. J. (2021) · Molecular Pharmacology · doi:10.1124/molpharm.121.000363 · Cited by 30
Self-citation
Pharmacological property optimization for allosteric ligands: A medicinal chemistry perspective
Johnstone, S., & Albert, J. S. (2017) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2017.03.084 · Cited by 27
Chemical Tools for Studying Lipid-Binding Class A G Protein–Coupled Receptors
Cooper, A. G., Singh, S., Hook, S. M., Tyndall, J. D. A., & Vernall, A. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013243 · Cited by 26
Monitoring Allosteric Interactions with CXCR4 Using NanoBiT Conjugated Nanobodies
Soave, M., Heukers, R., Kellam, B., Woolard, J., Smit, M. J., Briddon, S. J., & Hill, S. J. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.06.006 · Cited by 30
Spatial encryption of G protein-coupled receptor signaling in endosomes; Mechanisms and applications
Sposini, S., & Hanyaloglu, A. C. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.028 · Cited by 31
Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
Wu, A., Salom, D., Hong, J. D., Tworak, A., Watanabe, K., Pardon, E., Steyaert, J., Kandori, H., Katayama, K., Kiser, P. D., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40911-9 · Cited by 27
Self-citation
Is the Functional Response of a Receptor Determined by the Thermodynamics of Ligand Binding?
Vögele, M., Zhang, B. W., Kaindl, J. M., & Wang, L. (2023) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.3c00899 · Cited by 27
In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson’s Disease
Lemos, A., Melo, R., Preto, A. J., de Almeida, J. G., Moreira, I. S., & Cordeiro, M. N. D. S. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180308161642 · Cited by 28
The path to the G protein‐coupled receptor structural landscape: Major milestones and future directions
Kogut, M. M., Zara, Z., Nicoli, A., Steuer, A., Lopez‐Balastegui, M., Selent, J., Karanth, S., Koehler, M., Ciancetta, A., Abiko, L. A., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17314 · Cited by 28
Impact of G protein-coupled receptor heteromers in endocrine systems
Jonas, K., & Hanyaloglu, A. C. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.030 · Cited by 26
Design of Drug Efficacy Guided by Free Energy Simulations of the β 2 ‐Adrenoceptor
Panel, N., Vo, D. D., Kahlous, N. A., Hübner, H., Tiedt, S., Matricon, P. G., Pacalon, J., Fleetwood, O., Kampen, S., Luttens, A., et al. (2023) · Angewandte Chemie International Edition · doi:10.1002/anie.202218959 · Cited by 26
Generation of nanobodies from transgenic ‘LamaMice’ lacking an endogenous immunoglobulin repertoire
Eden, T., Schaffrath, A. Z., Wesolowski, J., Stähler, T., Tode, N., Richter, N., Schäfer, W., Hambach, J., Hermans‐Borgmeyer, I., Woens, J., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48735-x · Cited by 24
High-Affinity Functional Fluorescent Ligands for Human β-Adrenoceptors
Mitronova, G. Y., Lukinavičius, G., Butkevich, A. N., Kohl, T., Belov, V. N., Lehnart, S. E., & Hell, S. W. (2017) · Scientific Reports · doi:10.1038/s41598-017-12468-3 · Cited by 24
Re-engineering Electrochemical Aptamer-Based Biosensors to Tune Their Useful Dynamic Range via Distal-Site Mutation and Allosteric Inhibition
Li, S., Li, C., Wang, Y., Li, H., & Xia, F. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c02782 · Cited by 24
An Interpretable Convolutional Neural Network Framework for Analyzing Molecular Dynamics Trajectories: a Case Study on Functional States for G-Protein-Coupled Receptors
Li, C., Liu, J., Chen, J., Yuan, Y., Yu, J. H., Gou, Q., Guo, Y., & Pu, X. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00085 · Cited by 25
Nanobody GPS by PCS: An Efficient New NMR Analysis Method for G Protein Coupled Receptors and Other Large Proteins
Wu, F., Rieder, P. S., Abiko, L. A., Rößler, P., Gossert, A. D., Häußinger, D., & Grzesiek, S. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09692 · Cited by 25
Allosteric Regulation of the Follicle-Stimulating Hormone Receptor
Nataraja, S. G., Sriraman, V., & Palmer, S. S. (2018) · Endocrinology · doi:10.1210/en.2018-00317 · Cited by 24
A benchmark study of loop modeling methods applied to G protein-coupled receptors
Wink, L. H., Baker, D. L., Cole, J. A., & Parrill, A. L. (2019) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-019-00196-x · Cited by 24
Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery
Deepak, R. N. V. K., Verma, R. K., Hartono, Y. D., Yew, W. S., & Fan, H. (2021) · Pharmaceuticals · doi:10.3390/ph15010012 · Cited by 24
Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Chen, Y., Fleetwood, O., Pérez-Conesa, S., & Delemotte, L. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00826 · Cited by 23
Ligand-guided homology modeling drives identification of novel histamine H3 receptor ligands
Schaller, D., Hagenow, S., Stark, H., & Wolber, G. (2019) · PLoS ONE · doi:10.1371/journal.pone.0218820 · Cited by 22
Spatial regulation of GPR64/ADGRG2 signaling by β‐arrestins and GPCR kinases
Azimzadeh, P., Talamantez‐Lyburn, S. C., Chang, K. T., Inoue, A., & Balenga, N. A. B. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14227 · Cited by 22
Viral evasion of the integrated stress response through antagonism of eIF2-P binding to eIF2B
Schoof, M., Wang, L., Cogan, J. Z., Lawrence, R. E., Boone, M., Wuerth, J. D., Frost, A. S., & Walter, P. (2021) · Nature Communications · doi:10.1038/s41467-021-26164-4 · Cited by 22
A nanobody-based molecular toolkit provides new mechanistic insight into clathrin-coat initiation
Traub, L. M. (2019) · eLife · doi:10.7554/elife.41768 · Cited by 20
Differences between G‐Protein‐Stabilized Agonist–GPCR Complexes and their Nanobody‐Stabilized Equivalents
Saleh, N., Ibrahim, P., & Clark, T. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201702468 · Cited by 20
Interrogating Regulatory Mechanisms in Signaling Proteins by Allosteric Inhibitors and Activators: A Dynamic View Through the Lens of Residue Interaction Networks
Astl, L., Tse, A., & Verkhivker, G. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-8719-7_9 · Cited by 18
Genetically encoded intrabodies as high-precision tools to visualize and manipulate neuronal function
Trimmer, J. S. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.11.004 · Cited by 18
Recent Progress in Understanding the Conformational Mechanism of Heterotrimeric G Protein Activation
Duc, N. M., Kim, H. R., & Chung, K. Y. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2016.169 · Cited by 20
Protein 19F-labeling using transglutaminase for the NMR study of intermolecular interactions
Hattori, Y., Heidenreich, D. J., Ono, Y., Sugiki, T., Yokoyama, K.-I., Suzuki, E., Fujiwara, T., & Kojima, C. (2017) · Journal of Biomolecular NMR · doi:10.1007/s10858-017-0125-6 · Cited by 20
Conceptual and experimental issues in biased agonism
Onaran, H. O., & Costa, T. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.109955 · Cited by 20
Self-citation
Intersection of GPCR trafficking and cAMP signaling at endomembranes
Ripoll, L., von Zastrow, M., & Blythe, E. E. (2025) · The Journal of Cell Biology · doi:10.1083/jcb.202409027 · Cited by 21
Identifying G protein-coupled receptor dimers from crystal packings
Stenkamp, R. E. (2018) · Acta Crystallographica Section D Structural Biology · doi:10.1107/s2059798318008136 · Cited by 18
Agonist Binding and G Protein Coupling in Histamine H2 Receptor: A Molecular Dynamics Study
Conrad, M., Söldner, C. A., Miao, Y., & Sticht, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186693 · Cited by 19
MDPath: Unraveling Allosteric Communication Paths of Drug Targets through Molecular Dynamics Simulations
Doering, N. P., Taterra, M., Bermúdez, M., & Wolber, G. (2025) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.5c01590 · Cited by 19
Heterodimers Revolutionize the Field of Metabotropic Glutamate Receptors
Belkacemi, K., Rondard, P., Pin, J., & Prézeau, L. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.06.013 · Cited by 21
Selective Affimers Recognise the BCL‐2 Family Proteins BCL‐xL and MCL‐1 through Noncanonical Structural Motifs**
Miles, J. A., Hóbor, F., Trinh, C. H., Taylor, J. W., Tiede, C., Rowell, P. R., Jackson, B. R., Nadat, F., Ramsahye, P., Kyle, H. F., et al. (2020) · ChemBioChem · doi:10.1002/cbic.202000585 · Cited by 16
GPCR Activation States Induced by Nanobodies and Mini-G Proteins Compared by NMR Spectroscopy
Rößler, P., Mayer, D., Tsai, C., Veprintsev, D. B., Schertler, G. F. X., & Gossert, A. D. (2020) · Molecules · doi:10.3390/molecules25245984 · Cited by 18
NOP receptor pharmacological profile – A dynamic mass redistribution study
Malfacini, D., Simon, K., Trapella, C., Guerrini, R., Zaveri, N. T., Kostenis, E., & Calò, G. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203021 · Cited by 18
Biased Opioid Receptor Agonists: Balancing Analgesic Efficacy and Side-Effect Profiles
Ju, J., Li, Z., Liu, J., Peng, X., & Gao, F. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26051862 · Cited by 22
Noncanonical interactions of G proteins and β‐arrestins: from competitors to companions
Smith, J. S., & Pack, T. F. (2021) · FEBS Journal · doi:10.1111/febs.15749 · Cited by 17
New Horizons in Structural Biology of Membrane Proteins: Experimental Evaluation of the Role of Conformational Dynamics and Intrinsic Flexibility
Puthenveetil, R., Christenson, E. T., & Vinogradova, O. (2022) · Membranes · doi:10.3390/membranes12020227 · Cited by 18
Probing Allosteric Mechanism with Long-Range Rigidity Transmission Across Protein Networks
Sljoka, A. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-1154-8_5 · Cited by 16
Ultra low doses and biological amplification: Approaching Avogadro’s number
Calabrese, E. J., & Giordano, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105738 · Cited by 17
The DRY motif and the four corners of the cubic ternary complex model
Rovati, G. E., Capra, V., Shaw, V. S., Malik, R. U., Sivaramakrishnan, S., & Neubig, R. R. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.03.020 · Cited by 18
Development of an allosteric adhesion GPCR nanobody with therapeutic potential
Zheng, Y., Jiang, D., Lu, Y., Zhang, C., Huang, S.-M., Lin, H., Zhang, D., Guo, S., Han, J., Chen, J., et al. (2025) · Nature Chemical Biology · doi:10.1038/s41589-025-01896-2 · Cited by 15
G-protein coupled receptors in neuroinflammation, neuropharmacology, and therapeutics
Singh, A. P., Shadangi, S., & Rana, S. (2025) · Biochemical Pharmacology · doi:10.1016/j.bcp.2025.117301 · Cited by 16
Analyzing biased responses of GPCR ligands
Benredjem, B., Dallaire, P., & Piñeyro, G. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.11.008 · Cited by 16
Allosteric Modulator Leads Hiding in Plain Site: Developing Peptide and Peptidomimetics as GPCR Allosteric Modulators
Olson, K. M., Traynor, J. R., & Alt, A. J. (2021) · Frontiers in Chemistry · doi:10.3389/fchem.2021.671483 · Cited by 18
Auriculocondylar syndrome 2 results from the dominant-negative action of PLCB4 variants
Kanai, S. M., Heffner, C. S., Cox, T. C., Cunningham, M. L., Perez, F. A., Bauer, A. M., Reigan, P., Carter, C., Murray, S. A., & Clouthier, D. E. (2022) · Disease Models & Mechanisms · doi:10.1242/dmm.049320 · Cited by 14
Mechanistic basis of GPCR activation explored by ensemble refinement of crystallographic structures
Madsen, J. J., Ye, L., Frimurer, T. M., & Olsen, O. H. (2022) · Protein Science · doi:10.1002/pro.4456 · Cited by 15
Insight into structural properties of viral G protein‐coupled receptors and their role in the viral infection: IUPHAR Review 41
Tsutsumi, N., Kildedal, D. F., Hansen, O. K., Kong, Q., Schols, D., Loy, T. V., & ROSENKILDE, M. M. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17379 · Cited by 15
Programming the Dynamic Range of Nanochannel Biosensors for MicroRNA Detection Through Allosteric DNA Probes
Shang, Z., Ding, D., Deng, Z., Zhao, J., Yang, M., Xiao, Y., Chu, W., Xu, S., Zhang, Z., Yi, X., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202417280 · Cited by 15
Combined docking and machine learning identify key molecular determinants of ligand pharmacological activity on β2 adrenoceptor
Jiménez‐Rosés, M., Morgan, B. A., Sigstad, M. J., Tran, T. D. Z., Srivastava, R., Bunsuz, A., Roman, L. B., Hompluem, P., Cullum, S. A., Harwood, C. R., et al. (2022) · Pharmacology Research & Perspectives · doi:10.1002/prp2.994 · Cited by 15
Reprint of Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2
Lundström, L., Bissantz, C., Beck, J., Dellenbach, M., Woltering, T. J., Wichmann, J., & Gatti, S. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.040 · Cited by 15
Functional molecular switches of mammalian G protein-coupled bitter-taste receptors
Topin, J., Bouysset, C., Pacalon, J., Kim, Y., Rhyu, M., Fiorucci, S., & Golebiowski, J. (2021) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-03968-7 · Cited by 14
Solution NMR spectroscopy of GPCRs: Residue-specific labeling strategies with a focus on 13C-methyl methionine labeling of the atypical chemokine receptor ACKR3
Kleist, A. B., Peterson, F. C., Tyler, R. C., Gustavsson, M. B., Handel, T. M., & Volkman, B. F. (2018) · Methods in cell biology · doi:10.1016/bs.mcb.2018.09.004 · Cited by 14
Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates
Zupancic, J. M., Smith, M. D., Trzeciakiewicz, H., Skinner, M. E., Ferris, S. P., Makowski, E. K., Lucas, M. J., McArthur, N., Kane, R. S., Paulson, H. L., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1164080 · Cited by 13
Molecular Dynamics Simulations for the Determination of the Characteristic Structural Differences between Inactive and Active States of Wild Type and Mutants of the Orexin2 Receptor
Yokoi, S., & Mitsutake, A. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.0c10985 · Cited by 12
Nanobodies as Probes and Modulators of Cardiovascular G Protein–Coupled Receptors
Wingler, L. M., & Feld, A. P. (2021) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001185 · Cited by 13
Self-citation
NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRET
van den Bor, J., Bergkamp, N. D., Anbuhl, S. M., Dekker, F. A., Çömez, D., Almeria, C. V. P., Bosma, R., White, C. W., Kilpatrick, L. E., Hill, S. J., et al. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100422 · Cited by 13
Pharmacological characterization of seven human histamine H3 receptor isoforms
Gao, M., Dekker, M. E., Leurs, R., & Vischer, H. F. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176450 · Cited by 13
Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2
Lundström, L., Bissantz, C., Beck, J., Dellenbach, M., Woltering, T. J., Wichmann, J., & Gatti, S. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.08.032 · Cited by 13
Ligand-specific activation trajectories dictate GPCR signalling in cells
Thomas, R., Jacoby, P. S., Faveri, C. D., Derieux, C., Liebing, A., Melkes, B., Martini, H.-J., Bermúdez, M., Stäubert, C., Lohse, M. J., et al. (2026) · Nature · doi:10.1038/s41586-025-09963-3 · Cited by 12
Activation and Speciation Mechanisms in Class A GPCRs
Wingert, B. M., Doruker, P., & Bahar, İ. (2022) · Journal of Molecular Biology · doi:10.1016/j.jmb.2022.167690 · Cited by 12
Phosphorylation patterns in the AT1R C-terminal tail specify distinct downstream signaling pathways
Gareri, C., Pfeiffer, C. T., Jiang, X. C., Paulo, J. A., Gygi, S. P., Pham, U., Chundi, A., Wingler, L. M., Staus, D. P., Stępniewski, T. M., et al. (2024) · Science Signaling · doi:10.1126/scisignal.adk5736 · Cited by 11
Self-citation
Signalling in response to sub‐picomolar concentrations of active compounds: Pushing the boundaries of GPCR sensitivity
Civciristov, S., & Halls, M. L. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14636 · Cited by 14
Structural Insights into Partial Activation of the Prototypic G Protein-Coupled Adenosine A2A Receptor
Claff, T., Mahardhika, A. B., Vaaßen, V. J., Schlegel, J. G., Vielmuth, C., Weiße, R. H. ‐., Sträter, N., & Müller, C. E. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00051 · Cited by 11
Dynamical Correlations Reveal Allosteric Sites in G Protein-Coupled Receptors
Renault, P., & Giraldo, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010187 · Cited by 11
Optical tools to study the subcellular organization of GPCR neuromodulation
Jullié, D., Valbret, Z., & Stoeber, M. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109408 · Cited by 11

Authors: Staus, D. P., Strachan, R. T., Manglik, A., Pani, B., Kahsai, A. W., Kim, T. H., Wingler, L. M., Ahn, S., Chatterjee, A., Masoudi, A., Kruse, A. C., Pardon, E., Steyaert, J., Weis, W. I., Prosser, R. S., Kobilka, B. K., Costa, T., & Lefkowitz, R. J.
Affiliations: Duke Medical Center (US)
University of North Carolina at Chapel Hill (US)
Stanford Medicine (US)
University of Toronto (CA)
Harvard University (US)
Vrije Universiteit Brussel (BE)
Istituto Superiore di Sanità (IT)
Howard Hughes Medical Institute (US)
Corresponding author: Kobilka, Brian K.
Costa, Tommaso
Lefkowitz, Robert J.
ORCID: Strachan, Ryan T.
Manglik, Aashish
Pani, Biswaranjan
Kahsai, Alem W.
Kim, Tae Hun
Wingler, Laura M.
Ahn, Seungkirl
Masoudi, Ali
Kruse, Andrew C.
Pardon, Els
Steyaert, Jan
Weis, William I.
Prosser, R. Scott
Kobilka, Brian K.
Costa, Tommaso
Lefkowitz, Robert J.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2016-07
Volume: 535
Issue: 7612
Pages: 448-452
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature18636
PMC: PMC4961583
OpenAlex: W2471992026
Cited by: 330
References: 38
Citations by year: 2026: 11 · 2025: 18 · 2024: 23 · 2023: 28 · 2022: 26 · 2021: 46 · 2020: 36 · 2019: 47 · 2018: 43 · 2017: 39 · 2016: 13
FWCI: 25.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
eScholarship (California Digital Library) (submittedVersion)
VUBIR (Vrije Universiteit Brussel) (submittedVersion)
Funders: Howard Hughes Medical Institute
American Heart Association
Ministero della Salute (02351158, RF-201102351158)
National Heart, Lung, and Blood Institute (HL 16037, R01HL070631, HL-70631, T32HL007101, R01HL016037)
National Institute of General Medical Sciences (T32GM008294)
National Institute of Diabetes and Digestive and Kidney Diseases (T32DK007731)
National Institute of Neurological Disorders and Stroke (NS-028471, R01NS028471, R37NS028471)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
Keywords: beta2-adrenergic receptor, G protein-coupled receptor activation, receptor conformational states, three-state model, partial agonists, full agonists, ligand efficacy, receptor stabilization, orthosteric binding pocket, receptor dynamics
MeSH terms: Allosteric Regulation, Allosteric Site, Humans, Isoproterenol, Ligands, Models, Molecular, Protein Conformation, Receptors, Adrenergic, beta-2, Crystallography, X-Ray, Nuclear Magnetic Resonance, Biomolecular, Drug Partial Agonism, Protein Stability, Adrenergic beta-2 Receptor Agonists, Single-Domain Antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks